EBMT Study Links Graft Source to MF Engraftment

Company EBMT (registry study) Event Type Peer-reviewed registry analysis (Bone Marrow Transplantation) Modality Haploidentical hematopoietic cell transplant Asset Graft source and CD34+ dose Target Engraftment Disease Area Myelofibrosis Summary An EBMT registry analysis of 263 myelofibrosis patients undergoing haploidentical HCT reported primary graft failure in…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *